CDK2 and melanoma: Prognostic correlation analysis of cutaneous melanoma with molecular markers found that high expression of hsa-miR-500a-3p, CDK2 and POLR2A genes or low expression of hsa-miR-150-5p can significantly reduce OS in melanoma patients.